Noemi Laprovitera

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione et al. · Mechanisms of Ageing and Development · 2020 · 115 citations · Full text

Life Sciences, Clinical Sciences, Immunology +15

DNA Methylation of Shelf, Shore and Open Sea CpG Positions Distinguish High Microsatellite Instability from Low or Stable Microsatellite Status Colon Cancer Stem Cells

Rosa Visone, Maria Giulia Bacalini, Simone Di Franco et al. · Epigenomics · 2019 · 44 citations · Full text

Medicine, Molecular Biology, Oncology +17

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

M. Cinausero, Noemi Laprovitera, Giovanna De Maglio et al. · Therapeutic Advances in Medical Oncology · 2019 · 38 citations · Full text

Medicine, Molecular Genetics, Oncology +17

MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary

Noemi Laprovitera, Mattia Riefolo, Elisa Porcellini et al. · Molecular Oncology · 2021 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches

Noemi Laprovitera, Irene Salamon, Francesco Gelsomino et al. · Frontiers in Cell and Developmental Biology · 2021 · 24 citations · Full text

Medicine, Genetics, Oncology +17